Adult Gliosarcoma: Clinical Trials

45 trials for Adult Gliosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 9 terminated, 2 withdrawn, 1 active not recruiting. 45 Phase 1, 20 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 145Completed 33, Terminated 9, Withdrawn 2, Active not recruiting 1
Phase 220Completed 17, Terminated 2, Withdrawn 1

Follow Adult Gliosarcoma: new trials by email Literature Review of Adult Gliosarcoma trials Research Report on Adult Gliosarcoma

Trials (filtered) newest first · largest first

All 45 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients
MSC11FCD - Glioblastoma, Adult Gliosarcoma
Phase 1 / Phase 2CompletedCHA University102020-06-242023-01-18
EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
EGFRBi-Armed Autologous T Cells, Laboratory Biomarker Analysis - Adult Brain Glioblastoma, Adult Gliosarcoma
Phase 1 / Phase 2WithdrawnBarbara Ann Karmanos Cancer Institute2015-08-012016-02-15
Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Dimethyl Fumarate, Temozolomide, Radiation Therapy - Adult Brain Glioblastoma, Adult Giant Cell Glioblastoma
Phase 1CompletedVirginia Commonwealth University122015-02-132019-06-28
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
Hyperfractionated radiation therapy, Stereotactic radiosurgery, Alisertib - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University172015-01-302025-04-30
Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
radiation therapy, temozolomide, plerixafor - Adult Ependymoblastoma, Adult Giant Cell Glioblastoma
Phase 1 / Phase 2CompletedLawrence Recht302014-11-012018-10-23
Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas
E. coli CD-expressing genetically modified neural stem cells, flucytosine, leucovorin calcium - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma
Phase 1CompletedCity of Hope Medical Center162014-10-282026-11-03
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
18F-fludeoxyglucose (18F-FDG), 18F-FPPRGD2 - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 1 / Phase 2CompletedSanjiv Sam Gambhir252013-03-042019-10-03
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
Anti-Endoglin Chimeric Monoclonal Antibody TRC105, Bevacizumab, Laboratory Biomarker Analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)1162012-11-012018-05-23
High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma
Vorinostat, Stereotactic Radiosurgery, Laboratory Biomarker Analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma
Phase 1TerminatedNational Cancer Institute (NCI)302012-06-012014-12-23
RO4929097 in Treating Patients With Recurrent Invasive Gliomas
gamma-secretase/Notch signalling pathway inhibitor RO4929097, therapeutic conventional surgery, pharmacological study - Adult Anaplastic Oligodendroglioma, Adult Brain Stem Glioma
Phase 1TerminatedNational Cancer Institute (NCI)222011-07-012013-02-07
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
bafetinib, microdialysis, pharmacological study - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma
Phase 1CompletedCity of Hope Medical Center72010-12-012018-04-17
RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
gamma-secretase/Notch signalling pathway inhibitor RO4929097, bevacizumab, laboratory biomarker analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)132010-12-012015-12-14
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
flucytosine, polymerase chain reaction, immunohistochemistry staining method - Adult Anaplastic Astrocytoma, Recurrent Grade III Glioma
Phase 1CompletedCity of Hope Medical Center152010-08-012017-11-09
Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
aminolevulinic acid, laboratory biomarker analysis, therapeutic conventional surgery - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma
Phase 1TerminatedUniversity of Washington62010-06-012017-02-15
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
3-Dimensional Conformal Radiation Therapy, Gamma-Secretase Inhibitor RO4929097, Intensity-Modulated Radiation Therapy - Acoustic Schwannoma, Adult Anaplastic (Malignant) Meningioma
Phase 1CompletedNational Cancer Institute (NCI)222010-05-012015-09-29
Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
erlotinib hydrochloride, isotretinoin, laboratory biomarker analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma
Phase 1TerminatedWake Forest University Health Sciences52010-05-012018-08-01
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
Gamma-Secretase Inhibitor RO4929097, Cediranib Maleate, Pharmacological Study - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma
Phase 1CompletedNational Cancer Institute (NCI)202010-05-012014-12-23
Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
Cediranib Maleate, Cilengitide, Laboratory Biomarker Analysis - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 1CompletedNational Cancer Institute (NCI)472010-03-012015-04-15
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Laboratory Biomarker Analysis, Perifosine, Temsirolimus - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)362010-01-272021-07-19
Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
Cilengitide, Clinical Observation, Laboratory Biomarker Analysis - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 1TerminatedNational Cancer Institute (NCI)412009-12-012015-04-28

Showing 20 of 45. Sign in to see all of them.

Narrower conditions

Gliosarcoma (45)  ·  Glioblastoma (44)  ·  Brain Neoplasms (30)  ·  Astrocytoma (23)  ·  Oligodendroglioma (23)  ·  Glioma (17)  ·  Ependymoma (6)  ·  Neuroectodermal Tumors, Primitive (4)  ·  Breast Neoplasms (3)  ·  Breast Neoplasms, Male (3)  ·  Carcinoma, Non-Small-Cell Lung (3)  ·  Colonic Neoplasms (3)  ·  Glioma, Subependymal (3)  ·  Medulloblastoma (3)  ·  Meningioma (3)

Broader conditions

Neoplasms (45)  ·  Neoplasms by Histologic Type (45)  ·  Neoplasms, Glandular and Epithelial (45)  ·  Neoplasms, Nerve Tissue (45)  ·  Neoplasms, Neuroepithelial (45)  ·  Neuroectodermal Tumors (45)  ·  Neoplasms, Germ Cell and Embryonal (44)  ·  Brain Diseases (33)  ·  Central Nervous System Diseases (33)  ·  Neoplasms by Site (33)  ·  Nervous System Diseases (33)  ·  Nervous System Neoplasms (33)  ·  Central Nervous System Neoplasms (32)  ·  Glioma (28)  ·  Astrocytoma (21)

Interventions

Temozolomide (12)  ·  Radiation (7)  ·  Radiotherapy (7)  ·  Erlotinib Hydrochloride (5)  ·  Radiotherapy, Conformal (5)  ·  Sirolimus (5)  ·  temsirolimus (5)  ·  2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (4)  ·  Cilengitide (3)  ·  Magnetic Resonance Spectroscopy (3)  ·  Radiosurgery (3)  ·  Radiotherapy, Intensity-Modulated (3)  ·  Sorafenib (3)  ·  Vorinostat (3)  ·  cediranib (3)

Sponsors

National Cancer Institute (NCI) (33)  ·  City of Hope Medical Center (4)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  CHA University (1)  ·  Lawrence Recht (1)  ·  Sanjiv Sam Gambhir (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  University of Washington (1)  ·  Virginia Commonwealth University (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (41)  ·  Canada (2)  ·  South Korea (1)

Top investigators

Jana Portnow (4)  ·  Evanthia Galanis (2)  ·  Timothy Cloughesy (2)  ·  Antonio Omuro (1)  ·  Antonius Miller (1)  ·  Arnab Chakravarti (1)  ·  Daniel Silbergeld (1)  ·  David Brachman (1)  ·  David Peereboom, MD (1)  ·  Edward Pan, MD (1)  ·  Elizabeth Gerstner (1)  ·  Elizabeth R Gerstner, MD (1)  ·  Glenn Lesser (1)  ·  Howard Fine, MD (1)  ·  Jann Sarkaria (1)

Results publications

PMID 21377994, PMID 22517399, PMID 23380277, PMID 24309981, PMID 24470557, PMID 25113840, PMID 25832688, PMID 25965900, PMID 26062933, PMID 26611425, PMID 30825962, PMID 30850872, PMID 31386061, PMID 33842889, PMID 38197800

NIH funding

U01CA062399 (6), U01CA062475 (6), U01CA137443 (6), U10CA025224 (4), U10CA180821 (3), P30CA008748 (2), U01CA069856 (2), U10CA021661 (2), N01CM00032 (1), P30CA006516 (1), P30CA014599 (1), P30CA016059 (1), P30CA022453 (1), P30CA033572 (1), P30CA056036 (1)